0001104659-18-024255.txt : 20180629 0001104659-18-024255.hdr.sgml : 20180629 20180416171210 ACCESSION NUMBER: 0001104659-18-024255 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20180416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043404176 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 CORRESP 1 filename1.htm

 

ROPES & GRAY LLP

PRUDENTIAL TOWER

800 BOYLSTON STREET

BOSTON, MA 02199-3600

WWW.ROPESGRAY.COM

 

April 16, 2018

Paul M. Kinsella

 

T +1 617 951 7921

 

paul.kinsella@ropesgray.com

 

BY EDGAR

 

U.S. Securities and Exchange Commission

100 F. Street, N.H.

Washington, D.C. 20549

 

Re: Ironwood Pharmaceuticals, Inc.

Commission File Number: 001-34620

Preliminary Proxy Materials Relating to 2018 Annual Meeting of Stockholders

 

Ladies and Gentlemen:

 

On behalf of Ironwood Pharmaceuticals, Inc. (the “Company”), we are transmitting for filing under Rule 14a-6(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s preliminary proxy statement and form of proxy (the “Preliminary Proxy Materials”) relating to the Company’s 2018 Annual Meeting of Stockholders (the “Annual Meeting”).

 

The Company is filing the Preliminary Proxy Materials as a result of references contained therein to a potential “solicitation in opposition” (as defined in Rule 14a-6(a) of the Exchange Act) in connection with a notice from Sarissa Capital Offshore Master Fund LP stating that it intends to nominate an individual to stand for election to the Company’s Board of Directors at the Annual Meeting.

 

Please be advised that, in accordance with Rule 14a-6(h) of the Exchange Act, the Company intends to release definitive proxy materials on or prior to April 27, 2018 by sending to its shareholders a definitive proxy statement and form of proxy, as well as a copy of the Company’s annual report for the year ended December 31, 2017.

 

Please direct any communications concerning the Preliminary Proxy Materials to the undersigned at (617) 951-7921 or paul.kinsella@ropesgray.com or to my partner, Jeff Katz at (617)-951-7072 or jeffrey.katz@ropesgray.com.

 

Very truly yours,

 

 

 

/s/ Paul M. Kinsella

 

 

 

Paul M. Kinsella

 

 


GRAPHIC 2 g28284bgi001.jpg GRAPHIC begin 644 g28284bgi001.jpg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end